159 related articles for article (PubMed ID: 28011507)
21. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.
Goekkurt E; Al-Batran SE; Hartmann JT; Mogck U; Schuch G; Kramer M; Jaeger E; Bokemeyer C; Ehninger G; Stoehlmacher J
J Clin Oncol; 2009 Jun; 27(17):2863-73. PubMed ID: 19332728
[TBL] [Abstract][Full Text] [Related]
22. [A case of disseminated bone marrow carcinosis with disseminated intravascular coagulation successfully controlled with S-1 after total gastrectomy for advanced gastric cancer].
Katayama K; Okitsu H; Kimura S; Hara T; Ozaki K; Goto T; Yamashita M; Fujii Y
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1201-4. PubMed ID: 18633263
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
24. [A case of gastric cancer with DIC caused by multiple bone metastases treated with TS-1].
Fujishiro R; Naruse Y; Ichinose T; Yamazaki A; Sakamoto R
Gan To Kagaku Ryoho; 2006 May; 33(5):663-5. PubMed ID: 16685168
[TBL] [Abstract][Full Text] [Related]
25. Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer.
Koizumi W; Tanabe S; Azuma M; Ishido K; Nishimura K; Sasaki T; Nakatani K; Higuchi K; Nakayama N; Katada C
Int J Cancer; 2010 Jan; 126(1):162-70. PubMed ID: 19588501
[TBL] [Abstract][Full Text] [Related]
26. Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.
Arai H; Iwasa S; Boku N; Kawahira M; Yasui H; Masuishi T; Muro K; Minashi K; Hironaka S; Fukuda N; Takahari D; Nakajima TE
BMC Cancer; 2019 Jul; 19(1):652. PubMed ID: 31269916
[TBL] [Abstract][Full Text] [Related]
27. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
Amini A; Sanati H
Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective study.
Soularue É; Cohen R; Tournigand C; Zaanan A; Louvet C; Bachet JB; Hentic O; Samalin E; Chibaudel B; de Gramont A; André T;
Bull Cancer; 2015 Apr; 102(4):324-31. PubMed ID: 25744576
[TBL] [Abstract][Full Text] [Related]
29. [A case of gastric cancer accompanied by disseminated carcinomatosis of the bone marrow successfully controlled by S-1 and cisplatin combination therapy].
Ganno H; Nagahama T; Fukuda A; Takeuchi S; Fujiya K; Amagasa H; Kamikozuru H; Imai K; Ami K; Aoki N; Ando M; Arai K; Tei S; Ohbu M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2241-3. PubMed ID: 24394072
[TBL] [Abstract][Full Text] [Related]
30. [Two patients of progressive gastric cancer accompanied by disseminated carcinomatosis of bone marrow due to bone metastasis with DIC successfully controlled by combination of S-1 and CDDP].
Nishioka K; Kobayashi K; Aoki T; Hatano H; Komori T; Matsumoto T; Uemura Y
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2135-7. PubMed ID: 18219923
[TBL] [Abstract][Full Text] [Related]
31. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR
Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038
[TBL] [Abstract][Full Text] [Related]
32. [A patient with gastric cancer complicated with severe DIC and multiple bone metastasis showing a high response to combination of TS-1 and CDDP].
Yoshioka S; Tsujinaka T; Kida H; Hirao M; Fujitani K
Gan To Kagaku Ryoho; 2003 Mar; 30(3):403-6. PubMed ID: 12669401
[TBL] [Abstract][Full Text] [Related]
33. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.
Ajani JA; Rodriguez W; Bodoky G; Moiseyenko V; Lichinitser M; Gorbunova V; Vynnychenko I; Garin A; Lang I; Falcon S
J Clin Oncol; 2010 Mar; 28(9):1547-53. PubMed ID: 20159816
[TBL] [Abstract][Full Text] [Related]
34. Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.
Lin PH; Lu YS; Lin CH; Chang DY; Huang CS; Cheng AL; Yeh KH
Anticancer Res; 2010 Jul; 30(7):3087-91. PubMed ID: 20683060
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of quality of life by questionnaires between S-1/CPT-11 and mFOLFOX6 in patients with advanced colorectal cancer].
Tokunaga Y; Sasaki H; Matsueda S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1127-31. PubMed ID: 21772096
[TBL] [Abstract][Full Text] [Related]
36. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
Pozzo C; Barone C
Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
[TBL] [Abstract][Full Text] [Related]
37. Successful Treatment with 5-fluorouracil and Levofolinate Calcium in Advanced Gastric Cancer Patient with Disseminated Intravascular Coagulation.
Muto O; Munakata M; Yamagata K; Masuda A; Kotanagi K; Kichiraku T; Satoyoshi R; Kudoh K; Sawada T; Miyazawa H; Ouchi S; Kotanagi H; Sakata Y
Gan To Kagaku Ryoho; 2017 Oct; 44(10):867-869. PubMed ID: 29066681
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.
Louvet C; André T; Tigaud JM; Gamelin E; Douillard JY; Brunet R; François E; Jacob JH; Levoir D; Taamma A; Rougier P; Cvitkovic E; de Gramont A
J Clin Oncol; 2002 Dec; 20(23):4543-8. PubMed ID: 12454110
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2).
Nakata B; Tsuji A; Mitachi Y; Taenaka N; Kamano T; Oikawa K; Onoda N; Kambe M; Takahashi M; Shirasaka T; Morita S; Sakamoto J; Tanaka Y; Saji S; Hirakawa K
Oncology; 2010; 79(5-6):337-42. PubMed ID: 21430401
[TBL] [Abstract][Full Text] [Related]
40. Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
Ajani JA; Lee FC; Singh DA; Haller DG; Lenz HJ; Benson AB; Yanagihara R; Phan AT; Yao JC; Strumberg D
J Clin Oncol; 2006 Feb; 24(4):663-7. PubMed ID: 16446338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
